In insulin-treated type 2 diabetic patients, addition of metformin improves insulin sensitivity and glycemic control while allowing a reduction in the daily insulin dose (Cusi and DeFronzo, 1998). This evidence concerns the gene INS and type 2 diabetes mellitus.